{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T08:04:08Z","timestamp":1783238648470,"version":"3.54.6"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T00:00:00Z","timestamp":1659225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T00:00:00Z","timestamp":1659225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In clinical practice, the organs at risk (OARs) should be carefully determined when performing pancreatic stereotactic body radiotherapy (SBRT). We conducted a simulation study to examine the effect of the stomach size on the radiation dose to the OARs when performing pancreatic SBRT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Twenty-five cases were included in this study. Pancreatic head and body tumors were 2-cm-sized pseudotumors, which were included as gross target volume (GTV) contours. The stomach, pancreas, small intestine, liver, kidneys, and spinal cord were considered as the OARs. The prescription dose for planning target volume (PTV) was 40\u00a0Gy\/5fx, and the dose limit for the OARs was determined. The dose to X% of the OAR volume at X values of 0.1, 5.0, and 10.0\u00a0cc (DX) and the percentage of the OAR volume that received more than X Gy were recorded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In terms of the radiation dose to the pancreatic body tumors, the stomach size was positively correlated with a dose of D10cc [correlation coefficient (r)\u2009=\u20090.5516) to the stomach. The r value between the radiation dose to the pancreatic head tumor and the stomach size was 0.3499. The stomach size and radiation dose to the head and body of the pancreas were positively correlated (pancreatic head D10cc: r\u2009=\u20090.3979, pancreatic body D10cc: r\u2009=\u20090.3209). The larger the stomach, the larger the radiation dose to the healthy portion of the pancreas outside the PTV.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>When performing pancreatic SBRT, the dose to the OARs depends on the stomach size. Reducing the dose to the stomach and pancreas can be achieved by shrinking the stomach.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-022-02107-1","type":"journal-article","created":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T07:03:27Z","timestamp":1659251007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of stomach size on organs at risk in pancreatic stereotactic body radiotherapy"],"prefix":"10.1186","volume":"17","author":[{"given":"Osamu","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousei","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuto","family":"Nakaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Kiryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyoko","family":"Makita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,31]]},"reference":[{"key":"2107_CR1","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1002\/cncr.30856","volume":"123","author":"SWL de Geus","year":"2017","unstructured":"de Geus SWL, Eskander MF, Kasumova GG, Ng SC, Kent TS, Mancias JD, et al. Stereotactic body radiotherapy for unresected pancreatic cancer: a nationwide review. Cancer. 2017;123:4158\u201367.","journal-title":"Cancer"},{"key":"2107_CR2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ijrobp.2015.12.003","volume":"94","author":"S Krishnan","year":"2016","unstructured":"Krishnan S, Chadha AS, Suh Y, Chen HC, Rao A, Das P, et al. Focal radiation therapy dose escalation improves overall survival in locally advanced pancreatic cancer patients receiving induction chemotherapy and consolidative chemoradiation. Int J Radiat Oncol Biol Phys. 2016;94:755\u201365.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2107_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13014-018-1138-3","volume":"13","author":"C Goldsmith","year":"2018","unstructured":"Goldsmith C, Plowman PN, Green MM, Dale RG, Price PM. Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity. Radiat Oncol. 2018;13:204.","journal-title":"Radiat Oncol"},{"key":"2107_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13014-019-1309-x","volume":"14","author":"M Reyngold","year":"2019","unstructured":"Reyngold M, Parikh P, Crane CH. Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results. Radiat Oncol. 2019;14:95.","journal-title":"Radiat Oncol"},{"key":"2107_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.radonc.2019.01.020","volume":"134","author":"M Loi","year":"2019","unstructured":"Loi M, Magallon-Baro A, Suker M, van Eijck C, Sharma A, Hoogeman M, et al. Pancreatic cancer treated with SBRT: effect of anatomical interfraction variations on dose to organs at risk. Radiother Oncol. 2019;134:67\u201373.","journal-title":"Radiother Oncol"},{"key":"2107_CR6","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.ijrobp.2021.08.002","volume":"111","author":"JS Niedzielski","year":"2021","unstructured":"Niedzielski JS, Liu Y, Ng SSW, Martin RM, Perles LA, Beddar S, et al. Dosimetric uncertainties resulting from interfractional anatomic variations for patients receiving pancreas stereotactic body radiation therapy and cone beam computed tomography image guidance. Int J Radiat Oncol Biol Phys. 2021;111:1298\u2013309.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2107_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.600940","volume":"10","author":"R Mazzarotto","year":"2020","unstructured":"Mazzarotto R, Simoni N, Guariglia S, Rossi G, Micera R, De Robertis R, et al. Dosimetric feasibility study of dose escalated Stereotactic Body Radiation Therapy (SBRT) in locally advanced pancreatic cancer (LAPC) patients: it is time to raise the bar. Front Oncol. 2020;10: 600940.","journal-title":"Front Oncol"},{"key":"2107_CR8","first-page":"236","volume":"5","author":"TO Thomas","year":"2014","unstructured":"Thomas TO, Hasan S, Small W Jr, Herman JM, Lock M, Kim EY, et al. The tolerance of gastrointestinal organs to stereotactic body radiation therapy: what do we know so far? J Gastrointest Oncol. 2014;5:236\u201346.","journal-title":"J Gastrointest Oncol"},{"key":"2107_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.adro.2017.07.011","volume":"2","author":"K Plichta","year":"2017","unstructured":"Plichta K, Camden N, Furqan M, Hejleh TA, Clamon GH, Zhang J, et al. SBRT to adrenal metastases provides high local control with minimal toxicity. Adv Radiat Oncol. 2017;2:581\u20137.","journal-title":"Adv Radiat Oncol"},{"key":"2107_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1159\/000322505","volume":"43","author":"AY Minn","year":"2011","unstructured":"Minn AY, Koong AC, Chang DT. Stereotactic body radiation therapy for gastrointestinal malignancies. Front Radiat Ther Oncol. 2011;43:412\u201327.","journal-title":"Front Radiat Ther Oncol"},{"key":"2107_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.radonc.2017.05.013","volume":"124","author":"WG Campbell","year":"2017","unstructured":"Campbell WG, Jones BL, Schefter T, Goodman KA, Miften M. An evaluation of motion mitigation techniques for pancreatic SBRT. Radiother Oncol. 2017;124:168\u201373.","journal-title":"Radiother Oncol"},{"key":"2107_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.phro.2021.07.006","volume":"19","author":"N Tyagi","year":"2021","unstructured":"Tyagi N, Liang J, Burleson S, Subashi E, Scripes PG, Tringale KR, et al. Feasibility of ablative stereotactic body radiation therapy of pancreas cancer patients on a 1.5 tesla magnetic resonance-linac system using abdominal compression. Phys Imaging Radiat Oncol. 2021;19:53\u20139.","journal-title":"Phys Imaging Radiat Oncol."},{"key":"2107_CR13","doi-asserted-by":"publisher","first-page":"20190958","DOI":"10.1259\/bjr.20190958","volume":"93","author":"O Tanaka","year":"2020","unstructured":"Tanaka O, Sugiyama A, Omatsu T, Tawada M, Makita C, Matsuo M. Hemostasis radiotherapy for inoperable gastric cancer: a pilot study. Br J Radiol. 2020;93:20190958.","journal-title":"Br J Radiol"},{"key":"2107_CR14","first-page":"11","volume":"15","author":"O Tanaka","year":"2021","unstructured":"Tanaka O, Taniguchi T, Ono K, Nakaya S, Makita C, Kiryu T, et al. Adrenal stereotactic body radiation therapy: effects of a full and empty stomach on radiation dose to organs at risk. Onkologia I Radiotherapia. 2021;15:11\u20137.","journal-title":"Onkologia I Radiotherapia"},{"key":"2107_CR15","first-page":"1","volume":"14","author":"O Tanaka","year":"2020","unstructured":"Tanaka O, Ono K, Taniguchi T, Sakamoto N, Kiryu N, Makita C, et al. Hemostasis irradiation for gastric cancer: comparison of whole and partial stomach irradiation in the liver and kidney. Onkologia I Radioterapia. 2020;14:1\u20135.","journal-title":"Onkologia I Radioterapia"},{"key":"2107_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.prro.2012.03.005","volume":"3","author":"MJ Furman","year":"2013","unstructured":"Furman MJ, Whalen GF, Shah SA, Kadish SP. Gastric perforation following stereotactic body radiation therapy of hepatic metastasis from colon cancer. Pract Radiat Oncol. 2013;3:40\u20134.","journal-title":"Pract Radiat Oncol"},{"key":"2107_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ijrobp.2018.06.002","volume":"102","author":"MA Palacios","year":"2018","unstructured":"Palacios MA, Bohoudi O, Bruynzeel AME, de Koste JR, Cobussen P, Slotman BJ, et al. Role of daily plan adaptation in MR-guided stereotactic ablative radiation therapy for adrenal metastases. Int J Radiat Oncol Biol Phys. 2018;102:426\u201333.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2107_CR18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13014-016-0728-1","volume":"11","author":"F Walter","year":"2016","unstructured":"Walter F, Freislederer P, Belka C, Heinz C, S\u00f6hn M, Roeder F. Evaluation of daily patient positioning for radiotherapy with a commercial 3D surface-imaging system (Catalyst\u2122). Radiat Oncol. 2016;11:154.","journal-title":"Radiat Oncol"},{"key":"2107_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11547-021-01422-z","volume":"127","author":"F Gregucci","year":"2022","unstructured":"Gregucci F, Fiorentino A, Mazzola R, Ricchetti F, Bonaparte I, Surgo A, et al. Radiomic analysis to predict local response in locally advanced pancreatic cancer treated with stereotactic body radiation therapy. Radiol Med. 2022;127:100\u20137.","journal-title":"Radiol Med"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-022-02107-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-022-02107-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-022-02107-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T07:04:25Z","timestamp":1659251065000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-022-02107-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,31]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2107"],"URL":"https:\/\/doi.org\/10.1186\/s13014-022-02107-1","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,31]]},"assertion":[{"value":"28 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests..","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}